Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-08
  • 2025-07
  • 2025-06
  • Prostaglandin E2: Mechanisms, Benchmarks, and Research Ap...

    2026-02-16

    Prostaglandin E2: Mechanisms, Benchmarks, and Research Applications

    Executive Summary: Prostaglandin E2 (PGE2) is a lipid-derived autacoid that modulates inflammation and immune responses through four EP receptor subtypes (EP1–EP4) belonging to the GPCR family (APExBIO). PGE2 demonstrates both pro-inflammatory and anti-inflammatory actions by influencing dendritic cells, macrophages, and lymphocytes (https://doi.org/10.1016/j.jpba.2023.115540). It is crucial for gastrointestinal mucosal protection and cardiovascular homeostasis in vivo. PGE2 is widely used in research on inflammation, immune regulation, and reproductive medicine. APExBIO’s B7005 PGE2 is provided for scientific research with verified purity and solubility parameters (https://www.apexbt.com/prostaglandin-e2.html).

    Biological Rationale

    Prostaglandin E2 (PGE2) is an endogenous product of arachidonic acid metabolism. PGE2 is classified as a lipid-derived autacoid. It is synthesized in situ by cyclooxygenase (COX) enzymes and released by various cell types, including macrophages and endothelial cells. PGE2 production is rapidly upregulated during tissue injury and infection (Li et al., 2023). The compound acts locally to regulate immune cell activity, vascular tone, and mucosal integrity. Its pleiotropic effects are mediated by binding to four distinct G protein-coupled EP receptors, each with unique tissue distribution and signaling outcomes. PGE2 is essential for modulating both innate and adaptive immune responses. In the gastrointestinal system, PGE2 maintains mucosal blood flow and inhibits acid secretion, protecting tissue from injury (related article, which this article extends with specific product and application details).

    Mechanism of Action of Prostaglandin E2

    PGE2 exerts its biological effects by binding to EP1, EP2, EP3, and EP4 receptors. These receptors are members of the G protein-coupled receptor (GPCR) superfamily. Upon ligand binding, EP receptors activate intracellular signaling pathways, including cAMP, phospholipase C, and calcium mobilization. The diversity of EP receptor expression underlies the context-dependent actions of PGE2:

    • EP1: Activates phospholipase C, leading to increased intracellular Ca2+.
    • EP2/EP4: Stimulate adenylate cyclase, increasing cAMP and promoting anti-inflammatory responses.
    • EP3: Inhibits adenylate cyclase, decreasing cAMP and often mediating pro-inflammatory effects.

    PGE2 modulates dendritic cell maturation, T cell differentiation, and macrophage cytokine production. In HEK293 cellular assays, PGE2 binds the FP receptor with a Ki of 119 nM (APExBIO). This multiplicity of actions explains PGE2’s dual role in promoting and resolving inflammation (see also; this article clarifies receptor-specific mechanisms and research-grade standards).

    Evidence & Benchmarks

    • PGE2 is an established mediator of fever and pain via EP3 receptor activation (Li et al., 2023, DOI).
    • Orally administered PGE2 reduces indomethacin-induced gastrointestinal bleeding in rheumatic disease patients (clinical evidence, APExBIO product page).
    • PGE2 modulates dendritic cell and macrophage activity, impacting both innate and adaptive immunity (Li et al., 2023, DOI).
    • In cardiovascular models, PGE2 maintains homeostasis by regulating vascular tone and platelet aggregation (Li et al., 2023, DOI).
    • PGE2 binding affinity for the FP receptor in HEK293 cells is measured at Ki = 119 nM (experimental assay, APExBIO).
    • PGE2’s solubility in ethanol is ≥35.2 mg/mL and in DMSO is ≥42.8 mg/mL at room temperature; it is insoluble in water (product specification, APExBIO).

    Applications, Limits & Misconceptions

    PGE2 is widely used in inflammation research, gastrointestinal protection, immune regulation studies, and reproductive medicine. Its dual pro- and anti-inflammatory actions make it valuable for dissecting pathway-specific effects in vitro and in vivo. In cardiovascular research, PGE2 is applied to models of vascular tone and coronary heart disease (Li et al., 2023).

    PGE2 is also a benchmark compound for studying GPCR signaling. APExBIO’s B7005 reagent is used for scenario-driven laboratory experiments, enabling reproducible results in cell viability, proliferation, and receptor activation studies (see related article; this article updates with latest solubility and storage parameters).

    Common Pitfalls or Misconceptions

    • PGE2 is not water-soluble. Attempting aqueous dissolution leads to precipitation and inconsistent dosing.
    • PGE2’s effects are receptor- and context-dependent. Assuming uniform pro- or anti-inflammatory action is incorrect; effects vary with EP receptor subtype and cell type.
    • PGE2 is not suitable for diagnostic or direct clinical use. The APExBIO B7005 product is strictly for research applications.
    • Long-term solution storage is not recommended. Even at -20°C, PGE2 solutions may degrade; prepare fresh aliquots for reliable assays.
    • Overlooking batch-to-batch consistency can impact results. Use high-purity, research-grade PGE2 (such as APExBIO) to ensure reproducibility.

    Workflow Integration & Parameters

    For laboratory use, PGE2 stock solutions are typically prepared in DMSO at concentrations >10 mM. Gentle warming and ultrasonic treatment improve dissolution. Store aliquots at -20°C, avoiding repeated freeze-thaw cycles. The compound is shipped on blue ice to maintain stability (Prostaglandin E2 B7005).

    For cellular assays, optimal dosing depends on cell type, receptor expression, and research objectives. For example, HEK293 cells are often used for GPCR signaling studies, with binding affinity data supporting assay design.

    Internal resources such as Prostaglandin E2: Advancing Inflammation and Immune Research provide experimental best practices; this article supplements these with detailed product specifications and clinical evidence links.

    Conclusion & Outlook

    PGE2 remains a cornerstone molecule for dissecting the molecular underpinnings of inflammation, immune modulation, and mucosal protection. APExBIO’s research-grade PGE2 (SKU B7005) delivers consistency and reproducibility for advanced applications across cellular and organismal systems. Ongoing research continues to clarify the context-specific actions of PGE2 and its therapeutic potential in cardiovascular and gastrointestinal diseases. For up-to-date protocols and benchmarks, consult the APExBIO Prostaglandin E2 product page and the latest peer-reviewed research (Li et al., 2023).